FDA Strives to Expand Trial Enrollment.
The FDA issued a series of guidances to increase enrollment in clinical trials by expanding eligibility criteria. Targeted at industry, the guidances provide information about designing trials that include groups of patients that are typically excluded, such as those with HIV, hepatitis, or other comorbidities.